Search

everythinglearnresearchcommunity

for

Search:↓

FFA in men shows unique features and treatment results vary widely.

Hair loss from chronic cutaneous lupus erythematosus can sometimes be reversed with early, aggressive treatment.

Systemic minoxidil might help maintain hair regrowth in alopecia areata.

Hair disease research is a growing and evolving field in dermatology, with recent significant advances.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

The conference discussed various hair disorders and treatments, including the use of topical steroids, high doses of cetrizine, and hair grafting, as well as the psychological impact of hair loss.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

Iron deficiency may cause hair loss, but more research is needed.

The document suggests "Occupational Skin Disease" is a useful standard text, finds "The Clinical Management of Itching" poorly organized, recommends "Atlas of Contact Dermatitis" for its illustrations, and values "Handbook of Diseases of the Hair and Scalp" for its information despite flaws.

Extracorporeal shock waves significantly improve hair growth in women with female pattern hair loss.

Retinoids can both cause and treat different hair disorders.

Androgenetic alopecia, or common baldness, is the main cause of hair loss in men due to shrinking hair follicles from hormones, and it's normal but can be a problem if it's too much or too early.

Hair loss common in Australia; men affected earlier, more often than Asians; women less concerned.

Hair loss increases with age; alcohol raises risk, more female partners lowers it.

Baricitinib was effective in treating alopecia areata in two major trials.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

Epidermal Wnt/β-catenin signaling controls fat cell formation and hair growth.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.

Frequent hair coloring and styling can damage hair and cause breakage or loss.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Healthy hair is shiny, smooth, and has clean ends.

Cyclosporine showed some improvement in alopecia areata but results were not statistically significant.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Men with Kennedy disease have less chance of hair loss.

PRP therapy increases hair density for androgenetic alopecia.